A Novel Combined Tumor Budding-Poorly Differentiated Clusters Grading System Predicts Recurrence and Survival in Stage I-III Colorectal Cancer

Sameer Shivji, Richard Kirsch(University of Toronto), Carol J. Swallow(Princess Margaret Cancer Centre), David P. Cyr(Lunenfeld-Tanenbaum Research Institute), Kai Duan(University Health Network), Rossi Tomin, Cherry Pun(University of Toronto), Siham Zerhouni(Sinai Hospital), Deanna Ng(Mount Sinai Hospital), James Conner(University of Toronto), Erin Kennedy(Sinai Hospital), Ayşegül Sarı(Izmir Kâtip Çelebi University), Amanpreet Brar, Mantaj S. Brar
The American Journal of Surgical Pathology
May 25, 2022
10.1097/pas.0000000000001920
Cited by 22

Related Papers

Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2020|482
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
|Annals of Surgical Oncology|2021|243
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma
|Annals of Surgery|2022|138
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
|Nature Communications|2021|64
Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years
|Annals of Surgical Oncology|2020|56